首页> 外文期刊>International ophthalmology clinics >New diagnosis and treatment paradigms in acute retinal necrosis.
【24h】

New diagnosis and treatment paradigms in acute retinal necrosis.

机译:急性视网膜坏死的新诊疗范例。

获取原文
获取原文并翻译 | 示例
       

摘要

The first report in the medical literature of the uveitic entity known as acute retinal necrosis (ARN) was published in Japan in 1971.1 In the English literature, in 1977, two additional patients were described with a rapidly progressive retinal vasculitis that involved both the arteries and veins and was accompanied by retinal opacifkation.2 Both of these patients developed necrotic retinas and irreparable retinal detachments with final visual acuities of only light perception. This syndrome was given the name bilateral acute retinal necrosis in a 1978 description of 4 patients with bilateral processes similar to that described previously.3 Five of 8 eyes developed retinal detachments with breaks found at the border of normal and abnormal retina. Systemic workup was negative in all 4 patients. The etiology was hypothesized to be either an inflammatory or infectious retinitis. In 1982, a summary of the available medical literature on ARN codified the dismal prognosis of the disease entity that at that time had no known treatment.4 Sixty-six percent of cases were bilateral and 75% developed a retinal detachment that could only be successfully reattached in 22% of cases; 69% of eyes had a final visual acuity of hand motions or worse. The attempted treatments at the time which were universally ineffective included systemic or periocular steroids, cytotoxic chemotherapeutic agents, and use of transfer factor.
机译:1971.1在日本发表了有关葡萄膜实体的称为急性视网膜坏死(ARN)的医学文献的第一篇报道。在1977年的英语文献中,另外两名患者被描述为快速进行性视网膜血管炎,涉及动脉和动脉。静脉并伴有视网膜混浊。2这两名患者均出现坏死性视网膜和不可修复的视网膜脱离,最终的视力仅为光感知。在1978年的描述中,该综合征被命名为“双侧急性视网膜坏死”,名称为4例双侧过程,与先前描述的相似。38眼中有5眼出现了视网膜脱离,在正常和异常视网膜的边界处都有裂口。所有4例患者的全身检查均为阴性。病因被认为是炎性或感染性视网膜炎。 1982年,关于ARN的现有医学文献的摘要将当时尚无已知治疗的疾病实体的预后不良编成代码。4双侧病例中有66%患此病,而75%的患者发生了视网膜脱离,只能成功地在22%的案件中重新依附; 69%的眼睛的最终视力为手势动作或更差。当时普遍无效的尝试疗法包括全身或眼周类固醇,细胞毒性化疗药物和转移因子的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号